The Economist: Sam Glick On COVID’s Impact On Healthcare

Oliver Wyman partner Sam Glick was quoted in a story in The Economist about the impact of COVID on America’s health-care industry.

With new safety protocols, extended hours and virtual appointments, non-covid therapies could be nearly back to pre-covid levels within two months of the outbreak’s peak in a given region. Without such measures income might be 35% lower by then, according to Sam Glick of Oliver Wyman, a consultancy.

Health insurers look least vulnerable in the near term. Most have big enough buffers to withstand even a severe scenario for covid-19. However, next year may be tougher for insurers. Oliver Wyman estimates that six months after an outbreak starts in a region, they will see a “large and sustained rebound in costs”, as patients seek elective treatments.

To read the entire article, please click here.